High-dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseases.

about

High-dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseases.

Item

http://www.wikidata.org/entity/Q47567099

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

High-dose intravenous immunogl ...... tological autoimmune diseases.

@en

High-dose intravenous immunogl ...... tological autoimmune diseases.

@nl

type

Item

label

High-dose intravenous immunogl ...... tological autoimmune diseases.

@en

High-dose intravenous immunogl ...... tological autoimmune diseases.

@nl

prefLabel

High-dose intravenous immunogl ...... tological autoimmune diseases.

@en

High-dose intravenous immunogl ...... tological autoimmune diseases.

@nl

P1476

High-dose intravenous immunogl ...... tological autoimmune diseases.

@en

P2093

Alexander H Enk

http://www.w3.org/2001/XMLSchema#string

Jochen H O Hoffmann

http://www.w3.org/2001/XMLSchema#string

P2860

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia.

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura.

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

P304

1211-1226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1111/DDG.13389

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29228499

http://www.w3.org/2001/XMLSchema#string